Poor patient awareness and frequent misdiagnosis of migraine: findings from a large transcontinental cohort by Viana, M et al.
Poor patient awareness and frequent misdiagnosis of migraine:
findings from a large transcontinental cohort
M. Vianaa,b,c , F. Khaliqa,d, C. Zeccab,e , M. D. L. Figuerolaf,g, G. Sancesa, V. Di Pieroh, B. Petolicchioh,
M. Alessianih, P. Geppettii, C. Lupii, S. Benemeii, R. Iannaccheroj, F. Maggionik, M. E. Jurnol, S. Odobescum,
E. Chiriacm, A. Marfiln, F. Brighinao, N. Barrientos Uribep, C. Perez Lagoq, C. Bordinir, F. Luccheseh,
V. Maffeyh, G. Nappia, G. Sandrinia,s and C. Tassorellia,s
aHeadache Science Center, IRCCS Mondino Foundation, Pavia, Italy; bHeadache Center, Neurocenter of Southern Switzerland, Regional
Hospital Lugano, Lugano, Switzerland; cHeadache Group, Department of Basic and Clinical Neurosciences, King’s College London,
London; dScunthorpe General Hospital, North Lincolnshire, UK; eFaculty of Biomedical Sciences, Universita della Svizzera Italiana,
Lugano, Switzerland; fHospital de Clınicas Jose San Martın, Buenos Aires; gHospital Aleman, Buenos Aires, Argentina;
hSapienza University of Rome, Rome; iHeadache Center, Careggi University Hospital,University of Florence, Florence;
jA.O. ‘Pugliese – Ciaccio’, Catanzaro; kPadua University, Padua, Italy; lFAME/FUNJOB and FHEMIG, Barbacena, Brazil;
mNational Headache Center, Institute of Neurology and Neurosurgery of Chisinau City, Chisinau, Moldova; nHospital Universitario,
Monterrey, Mexico; oHeadache Center, Department BIONEC, University of Palermo, Palermo, Italy; pHospital DIPRECA, Las Condes,
Chile; qHospital Maciel, Montevideo, Uruguay; rClınica Neurologica Batatais, Batatais, Brazil; and sDepartment of Brain and Behavioral
Sciences, University of Pavia, Pavia, Italy
Keywords:
cervical, error, exam,
headache, management,
misdiagnosis, treatment,
underdiagnosis
Received 24 May 2019
Accepted 27 September 2019
European Journal of
Neurology 2019, 0: 1–6
doi:10.1111/ene.14098
Background and purpose: Although migraine is the second most disabling
condition worldwide, there is poor awareness of it. The objective was to assess
the awareness of migraine and previous diagnostic and therapeutic consulta-
tions and treatments in a large international population of migraineurs.
Methods: This was a multicentre study conducted in 12 headache centres in
seven countries. Each centre recruited up to 100 patients referred for a first
visit and diagnosed with migraine. Subjects were given a structured clinical
questionnaire-based interview about the perceptions of the type of headache
they suffered from, its cause, previous diagnoses, investigations and treat-
ments.
Results: In all, 1161 patients completed the study. Twenty-eight per cent of
participants were aware that they suffered from migraine. Sixty-four per cent
called their migraine ‘headache’; less commonly they used terms such as ‘cervi-
cal pain’ (4%), tension headache (3%) and sinusitis (1%). Eight per cent of
general practitioners and 35% of specialists (of whom 51% were neurologists
and/or headache specialists) consulted for migraine formulated the correct
diagnosis. Before participating in the study, 50% of patients had undergone
X-ray, computed tomography and/or magnetic resonance imaging of the cervi-
cal spine and 76% underwent brain and/or cervical spine imaging for
migraine. Twenty-eight per cent of patients had received symptomatic
migraine-specific medications and 29% at least one migraine preventive medi-
cation.
Conclusions: Although migraine is a very common disease, poor awareness of
it amongst patients and physicians is still an issue in several countries. This
highlights the importance of the promotion of migraine awareness to reduce
its burden and limit direct and indirect costs and the risk of exposure to use-
less investigations.
Correspondence: M. Viana, Headache Science Center, Mondino National Neurological Institute, Via Mondino 2, 27100 Pavia, Italy (tel.: +39
347 0740642; fax.: +39 038 2380286; e-mail: michele.viana@ymail.com).
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Introduction
Migraine is the third most frequent disorder world-
wide with a 1-year prevalence of 14.7% [1] and is the
second most disabling disease globally [2,3].
Until recent years, migraine remained underdiag-
nosed and undertreated [4–7]. This is probably due to
the facts that patients choose to self-diagnose or not
seek professional care for a number of reasons [8,9],
and non-specialized professionals often misdiagnose
migraine with other diseases. The most frequent alter-
native misdiagnoses are ‘sinusitis’ [10,11], ‘allergy’
[11], ‘cervical pain syndrome’ [12] and tension-type
headache [7,8]. Importantly, a large proportion of
patients who believe they suffer from one of the latter
conditions undergo unnecessary medical imaging
including radiation exposure in 40% of cases and
receive inappropriate treatments [10,12].
In this study, the aim was to assess whether patients
belonging to a large population of migraineurs seen at
tertiary headache centres in seven countries were
aware they were suffering from migraine, and to docu-
ment prior specific diagnostic and therapeutic consul-
tations and treatments.
Methods
This was a multicentre study conducted at 12 head-
ache centres in seven countries worldwide (Table 1).
One of the main requirements for selecting researchers
was good translation capabilities. The study was
approved by local ethics committees of each partici-
pating centre. All patients gave informed consent
before taking part in the study.
The study was conducted between 1 July 2015 and
31 October 2016. Each centre was asked to recruit 100
consecutive patients, with the lowest acceptable num-
ber set at 50 subjects.
Inclusion criteria were (i) subjects aged 18–75 years
referred to the headache centre/clinic for a first visit;
(ii) diagnosis of episodic migraine with aura and/or
migraine without aura and/or chronic migraine
according to the International Classification of Head-
ache Disorders 3rd edition (ICHD-III beta) criteria
[13]. Exclusion criteria were (i) subjects who were not
native speakers for the national language and (ii) sub-
jects with a headache onset within the previous year.
Procedures
At each site patients were evaluated by a neurologist
certified as a headache specialist, who diagnosed the
type of headache via ICHD-III beta criteria [13] dur-
ing a regular consultation. All consecutive patients
diagnosed with migraine and willing to participate
were recruited after obtaining informed consent.
Included patients were asked nine questions by the
treating neurologist. The following topics were cov-
ered: (i) the names the patients gave their headache
before the visit; (ii) what patients thought was/were
the cause(s) of their headaches; (iii) what diagnosis(es)
they received from their general practitioner (GP) or
other medical professionals; (iv) which visits and
para-clinical exams they performed/underwent for
migraine; (v) which treatments (either pharmacological
or non-pharmacological) they tried specifically for
migraine; (vi) if they had first and/or second degree
relatives affected with migraine. The neurologist
Table 1 Number of participants recruited by centre per country
Country Headache centre
No. of
participants
per centre
No. of
participants
(total per country
out of the whole
population) (%)
Brazil Medicine School of Barbacena (FAME/FUNJOB) and Hospital Foundation of Minas Gerais 101 101 (8.7)
Italy Mondino National Neurological Institute, Pavia 102 602 (51.9)
Interdepartmental Center for Headache and Drug Abuse, Padua University, Padua 104
University of Florence and Headache Center, Careggi University Hospital, Florence 85
Headache Center, Azienda Ospedaliera ‘Pugliese – Ciaccio‘ Catanzaro 100
Headache Center, Department of Neurology and Psychiatry, Sapienza University, Rome 102
Headache Center, Policlinico Universitario di Palermo, Palermo 109
Moldovia National Headache Center, Republic of Moldova 100 100 (8.6)
Mexico Clınica de Cefaleas y Dolor Cronico No Oncologico, Hospital Universitario, Monterrey 100 100 (8.6)
Argentina Centro de cefaleas, Hospital de Clınicas Jose San Martın, Buenos Aires 100 143 (12.3)
Servicio de Neurologıa, Hospital Aleman, Buenos Aires 43
Chile Dipreca Headache Center, Santiago 56 56 (4.8)
Uruguay Headache Center, Hospital Maciel, Servicio de Neurologıa, Montevideo 59 59 (5.1)
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conducting the consultation read the questions from a
questionnaire to the patients in the official language
spoken in each participating country (Italian, Por-
tuguese, Romanian, Spanish).
The questionnaire was developed in English
(Appendix S1)) and subsequently translated to the
national language by a panel of researchers for each
country. Guidelines reported in ‘Translation protocol
for hybrid documents’ [14] were followed to ensure a
high quality of translation. The first version of the ques-
tionnaire in the four languages was back-translated into
English by a translator to check for appropriateness of
translation, finally creating the back-checked consensus-
based translation for each of the four languages.
Following completion, each researcher uploaded the
patients’ answers, socio-demographic data (age, gen-
der, country region, educational and socio-economic
level) and clinical data (pain characteristics, presence
of associated symptoms such as nausea, vomiting,
photo/phonophobia) on a structured form on a dedi-
cated web platform (http://www.protocolliweb.com/
themigrainequestionnaire).
All the open-text answers (OTAs) were translated
into English by researchers before being inserted into
the database. A second independent review performed
by another researcher belonging to the same language
group was performed to ensure a correct translation
of the OTAs. Two researchers (MV and FK) indepen-
dently categorized the OTAs. Any disagreement
between the two authors was resolved by consensus
by involving a third person (CT).
The Coordinator Centre (Mondino National Neu-
rological Institute, Pavia, Italy) performed the analysis
of the data.
Statistic procedures
The Statistical Package for Social Sciences (SPSS) ver-
sion 24 was used for the statistics. Data are presented
as mean  SD (range) for continuous variables and
as n/% for categorical variables. Analyses of variance
(ANOVAs) were carried out to evaluate differences
between subgroups of patients belonging to the same
country (n = 7). Pearson’s chi-squared tests were used
for 2 9 7 tables in order to compare proportions
amongst the seven groups. Comparison of the seven
participating countries in the study was assessed by
using univariate analysis. Due to multiple testing over
13 variables, adjusted P values based on the Bonfer-
roni correction were considered. The significance level
was therefore lowered to P < 0.0038 (P = 0.05/13).
Differences in socio-demographics and clinical vari-
ables were also compared by using univariate analysis
between two groups: (i) migraine patients who were
aware they suffered from migraine and those who
were not, and (ii) migraine patients who believed they
suffered from ‘cervical pain attacks’ (CP) and those
who did not. Following this, a multivariate analysis
was carried out. In this analysis, only those variables
that had a statistical significance of P < 0.15 in the
univariate analysis were considered. As a multivariate
analysis was applied for such variables, Bonferroni
correction was not strictly required. Such analysis
identifies variables that are independent risk factors.
A value of P < 0.05 was considered significant. All P
values were two-tailed.
Results
All participating centres enrolled at least 50 patients
each, accounting overall for 1161 participants. The
distribution of patients across headache centres/coun-
tries is reported in Table 1. Around half of partici-
pants (n = 602) were recruited from Italy. Nine
hundred and thirteen (78.6%) patients were female,
and the mean (SD) age was 39  13 years. Seven
hundred and seventy-five subjects (66.8%) had a high
education level (high school or university). Other
characteristics of the subjects and features of migraine
attacks as well as migraine history are reported in
Table S1.
Of 1161 patients, 326 (28%) were aware that they
suffered from migraine whilst 64% of the whole popu-
lation called their migraine ‘a headache’. Other less
commonly used terms were CP (4%, mostly in Italy),
tension headache (3%, mostly in Mexico, Chile and
Uruguay) and sinusitis (1%) (Table S2).
All patients had previously visited a GP for their
migraine and only 28% of patients were correctly
diagnosed with the disorder (Table S3). Eighty per
cent of patients had visited at least one specialist for
their migraine (Table S4). Of these, 51% were neurol-
ogists and/or headache specialists and 35% formu-
lated the correct diagnosis (Table S3). Overall 13% of
patients were accurately diagnosed by both their GP
and another specialist. With respect to diagnostics,
50% of patients (N = 577) were prescribed with an X-
ray and/or computed tomography (CT) and/or mag-
netic resonance imaging (MRI) of the cervical spine,
whereas 76% of patients (N = 890) underwent imag-
ing of the brain and/or cervical spine that exposed
them to radiation (Table S4).
Three hundred and twenty-nine patients (28%) of
our whole migraine population had previously
received a symptomatic migraine-specific medication
(triptans and/or ergots) (Table S5), of whom 64%
(N = 212) reported having received a diagnosis of
migraine by a GP. Twenty-nine per cent (N = 342)
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had received at least one migraine preventive medica-
tion (Table S5) of whom 81% (N = 276) reported
having received a diagnosis of migraine by a GP.
Thirty-eight per cent (N = 124) of patients correctly
diagnosed with migraine by their GP and 38%
(N = 161) of those accurately diagnosed with migraine
by another practitioner received migraine-specific
medications.
When comparing characteristics of patients across
different countries, it was found that subjects from
Mexico had the highest rate of awareness of their
migraine (51%) followed by Chile (39%), Argentina
(34%), Brazil (30%), Italy (25%), Moldova (17%)
and Uruguay (12%) (Table S6).
The highest rates of previous migraine diagnosis by
another physician were seen in Argentina (68%, spe-
cialist MD), Mexico (66%, GP), Moldova (53%, spe-
cialist MD) and Uruguay (52%, specialist MD).
Despite being differently prevalent across different
countries, stress was reported as the most frequent
trigger of headache by patients, including 68% and
29.4% of patients from Mexico and Italy respectively
(Table S6).
On multivariate analyses, high educational level
[odds ratio (OR) 1.97, 95% confidence interval (CI)
1.43–2.78, P < 0.001], number of family members with
migraine (OR 1.17, 95% CI 1.04–1.31, P = 0.005),
throbbing pain (OR 2.02, 95% CI 1.23–3.31,
P = 0.005), lateralization of pain (OR 1.36, 95% CI
1.01–1.83, P = 0.043) and vomiting (OR 1.43, 95% CI
1.06–1.93, P = 0.018) independently increased the like-
lihood of being aware of the diagnosis of migraine,
whilst a shorter duration of attacks decreased it (OR
0.98, 95% CI 0.97–0.99, P = 0.001). The output of
the univariate analysis and the list of variables that
were included in the multivariate analysis are reported
in Table S7.
At univariate analysis patients who believed they
suffered from CP (n = 51) more frequently experi-
enced bilateral pain (P = 0.001) and pain located to
the back of the head (P < 0.001). Only these two vari-
ables reached a P value of < 0.15 in the analysis and
were therefore entered into the multivariate analysis.
Only pain in the back of the head remained signifi-
cantly associated with the self-diagnosis of CP on
multivariate analysis (OR 2.53, 95% CI 1.22–5.23,
P = 0.012).
Discussion
In this international multicentre study, the intention
was to assess the current state of patient awareness of
migraine in a large international population of migrai-
neurs. It was found that only 28% of patients were
aware that they were experiencing migraine. This is
quite surprising considering that these patients had
already seen at least one doctor and 80% at least one
head and neck pathology specialist before their visit
to one of the study centres. Even more remarkably,
about half of patients had specifically visited another
neurologist/headache centre for their current head-
ache, implying a previous incorrect or misunderstood
diagnosis.
Accordingly, less than one-third of patients received
migraine-specific symptomatic and migraine preventive
medication. Previous studies on a US migraine popu-
lation found that only 20% of patients treated their
acute attacks with prescribed medications [15] and
12% of migraineurs used a daily preventive migraine
medication [16].
More than half of our study population was Ital-
ian, and our results are in line with those of
another Italian study showing that, amongst 2675
patients with migraine attending a headache centre
for the first time, only 26.8% had been previously
identified as migraineurs, although 62.4% of them
had consulted their GP and 38.2% a headache spe-
cialist in the previous year [6]. In another prospec-
tive study involving over 77 000 Mexican women,
migraine was identified by means of questionnaires
in 19% of the population, 45.1% of these having
received a correct diagnosis [17]. This figure is
higher than ours overall; however, when stratifying
patients according to different countries, the propor-
tion was found to be as high as 66% in Mexico.
The great variability of migraine misdiagnosis by
GPs, but also neurologists and other specialists,
across countries probably reflects different substrates
that need to be separately addressed in future stud-
ies, possibly including issues related to different
medical education and practice.
Sixty-seven per cent of patients termed their
migraine simply a headache, and other names were
used rather infrequently. Interestingly, the term CP
was used by 4.4% of the overall population and by
90% of Italian patients, probably reflecting different
cultural backgrounds. Similar to our findings, in a
previous study 62.3% of migraine patients attending
an Italian headache centre termed their headache CP
[12]. The localization of pain to the back of the head
increased the misbelief that it was CP by 2.5-fold
according to multivariate analysis, and in line with
previous findings [12].
At least 50% of patients were prescribed with an X-
ray and/or CT and/or MRI of the cervical spine, sug-
gesting that a large proportion of GPs suspected the
diagnosis of cervicogenic headache, a rarer condition
with a clear-cut phenotype [18].
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A finding of concern is that 76% of patients under-
went examinations that exposed them to radiation.
These should only be prescribed by the practitioner in
the case of ‘red flags’ or atypical phenotypes in clini-
cal practice and it is unlikely that this was the case in
such a high proportion of our participants [19]. Some
studies highlight that even in paediatric patients the
use of CT scan to diagnose headache remains high
despite existing guidelines [20].
Subjects who were aware that they suffered from
migraine had a high educational level (74.8% vs.
63.6%, P < 0.001), or had an affected family member
(68.4% vs. 61.6%, P = 0.032), probably reflecting
more rapid and efficient access to information and/or
medical care in these conditions. Interestingly, lateral
head pain, pain aggravation by physical activity and
association with vomiting and phonophobia were also
associated with awareness of migraine, suggesting that
more specific clinical features help patients and/or
physicians distinguish migraine from other causes of
neck/head pain. These findings were not consistently
replicated when stratifying patients by country, indi-
cating that pain perception and interpretation is lar-
gely influenced by the different sociocultural
backgrounds [21].
Overall, these results support the importance of
campaigns to improve awareness of migraine amongst
patients and practitioners. Such measures to improve
migraine knowledge should be customized for each
country to properly address the specific misbeliefs
(with respect to types of misdiagnosis and wrong diag-
nostic and/or therapeutic paths). Considering a study
published in 2013, which highlighted high rates of
misdiagnosis and diagnostic and/or therapeutic errors
in trigeminal autonomic cephalalgias and hemicrania
continua [22], it is suggested that awareness cam-
paigns should also include such disabling headache
types.
The limitations of our study must be considered.
First, it was performed on patients who had been
referred to tertiary headache centres and therefore
findings in our sample cannot be generalized to all
migraine patients. Yet, it is likely that awareness of
migraine would be even lower in the general popula-
tion. Secondly, the questionnaire is based on the
patient’s report, and therefore it is possible that the
number of misdiagnoses by previous physicians is
overestimated due to lack of patient’s understanding
rather than incorrect diagnosis.
Furthermore, the questionnaire was administered
by a specialist; therefore interviewer bias may have
taken place. Similarly, the questionnaire was trans-
lated into four different languages as appropriate for
each headache centre. Although there is confidence
with the translation of the questionnaire, the possibil-
ity that the translation of patients’ answers from the
native language into English could have led to some
differences cannot be ruled out.
Moreover, our study used a non-validated question-
naire and is exposed to possible recall biases. How-
ever, it is believed that this type of questionnaire
represents the best trade-off in this setting, i.e. collect-
ing information on patient’s perception in large popu-
lations, and unfortunately no similar questionnaires
are available which have been validated so far.
Finally, there was an unequal number of participants
recruited from each country with more than 50% of
participants being recruited from Italy, making other
groups less representative of their respective countries.
Although variable across countries, it was found
that poor awareness of migraine amongst sufferers
and those doctors they sought consultation from led
to unnecessary risk exposure and costs, and prevented
or delayed access to appropriate treatments.
This is still occurring despite current international
guidelines which have been translated into many lan-
guages. This suggests that different strategies need to
be pursued to increase awareness of this medical
condition.
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